Evrópusambandið - búlgarska - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - Имуносупресори - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).

Evrópusambandið - búlgarska - EMA (European Medicines Agency)

astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - Антинеопластични средства - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.

Evrópusambandið - búlgarska - EMA (European Medicines Agency)

tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - Други стомашно-чревния тракт и обмяната на веществата средства, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.

Evrópusambandið - búlgarska - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - Имуносупресори - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

Evrópusambandið - búlgarska - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - Цитомегаловирусни инфекции - Антивирусни средства за системно приложение - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). Трябва да се вземат предвид официалните препоръки за правилното използване на антивирусни лекарства.

Evrópusambandið - búlgarska - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - Множествена Склероза, Рецидивно-Ремиттирующее - Имуносупресори - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Evrópusambandið - búlgarska - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - deucravacitinib - псориазис - Имуносупресори - treatment of moderate-to-severe plaque psoriasis in adults.

Evrópusambandið - búlgarska - EMA (European Medicines Agency)

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - анти-туморни агенти - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Evrópusambandið - búlgarska - EMA (European Medicines Agency)

teva b.v. - доксорубицин хидрохлорид - Неоплазми на гърдата - Антинеопластични средства - myocet липосомальный, в съчетание с циклофосфамидом, е предназначен за първа линия на терапия метастатичен рак на гърдата при жени.

Evrópusambandið - búlgarska - EMA (European Medicines Agency)

alfasigma s.p.a. - метилтионинов хлорид - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.